Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1577062 | 0.89 | CYP3A4 (0.41) | CYP3A4TDP1 | |
| SCHEMBL3075389 | 0.89 | CYP3A4 (0.41) | CYP3A4TDP1 | |
| SCHEMBL301087 | 0.89 | CYP3A4 (0.41) | CYP3A4TDP1TP53CES2CES1 | |
| SCHEMBL9492394 | 0.88 | TSHR (0.33) | CYP3A4TDP1CES2CES1 | |
| SCHEMBL1241769 | 0.87 | CYP3A4 (0.39) | CYP3A4TDP1TP53CES2CES1 | |
| SCHEMBL163845 | 0.84 | TDP1 (0.41) | CYP3A4TDP1TP53CES2CES1 | |
| Dimethylamine SCHEMBL10849585 | 0.83 | CYP3A4 (0.36) | CYP3A4TDP1TP53CES2CES1 | |
| SCHEMBL9403468 | 0.83 | CYP3A4 (0.36) | CYP3A4TDP1TP53CES2CES1 | |
| SCHEMBL9650051 | 0.82 | TDP1 (0.39) | CYP3A4TDP1TP53CES2CES1 | |
| SCHEMBL3068169 | 0.82 | TDP1 (0.39) | CYP3A4TDP1TP53CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8957181-B2 | Preparation process for cyclic conjugated polymer and polymerization catalyst for cyclic conjugated polymer | SOKEN CHEMICAL & ENGINEERING CO., LTD. (JP) | 2015-02-17 | — | — | US | disclosed |
| US-20130116481-A1 | CONVERSION OF ALCOHOLS | BP Biofuels UK Limited (GB) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116481-A1 | CONVERSION OF ALCOHOLS | ADH1C, ADH1A, ADH5 | CYP3A4 864/4885TDP1 3284/4885TP53 3642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.